HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dartevelle, P. Articles by Merlier, M. Search for Related Content PubMed PubMed Citation Articles by Dartevelle, P. Articles by Merlier, M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 94, 361-366, Copyright © 1987 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Replacement of the superior vena cava with polytetrafluoroethylene grafts combined with resection of mediastinal-pulmonary malignant tumors. Report of thirteen cases

P Dartevelle, A Chapelier, M Navajas, P Levasseur, A Rojas, J Khalife, E Lafontaine and M Merlier

From 1979 to 1986, we replaced the superior vena cava with polytetrafluoroethylene grafts in 13 patients to enable resection of malignant mediastinal or pulmonary tumors. Five prostheses could be interposed between a tumor-free proximal superior vena cava and right atrium while eight required separate innominate anastomoses (Y grafts constructed intraoperatively). There were no deaths. Phlebograms obtained 15 to 30 days after the operation demonstrated patency in 12 of 13 patients. Long-term (average 24 months) patency was evident in eight. Five patients are alive at 1, 3, 40, 49, and 60 months, a cumulative survival rate of 27% at 3 years.

This article has been cited by other articles:

				A. M. Ciccone, F. Venuta, A. D'Andrilli, C. Andreetti, M. Ibrahim, T. De Giacomo, D. Massullo, and E. A. Rendina Long-term patency of the stapled bovine pericardial conduit for replacement of the superior vena cava Eur J Cardiothorac Surg, December 1, 2011; 40(6): 1487 - 1491. [Abstract] [Full Text] [PDF]

				L. Spaggiari, F. Petrella, F. Leo, G. Veronesi, P. Solli, A. Borri, D. Galetta, R. Gasparri, and P. Scanagatta Superior vena cava resection for lung and mediastinal malignancies MMCTS, January 1, 2006; 2006(1009): mmcts.2005.001511 - mmcts.2005.001511. [Abstract] [Full Text] [PDF]

				Y. Shintani, M. Ohta, M. Minami, H. Shiono, H. Hirabayashi, M. Inoue, G. Matsumiya, and H. Matsuda Long-term graft patency after replacement of the brachiocephalic veins combined with resection of mediastinal tumors J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 809 - 812. [Abstract] [Full Text] [PDF]

				K. Suzuki, H. Asamura, S.-i. Watanabe, and R. Tsuchiya Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Ann. Thorac. Surg., October 1, 2004; 78(4): 1184 - 1189. [Abstract] [Full Text] [PDF]

				B. J. Park, M. Bacchetta, M. S. Bains, R. J. Downey, R. Flores, V. W. Rusch, and L. N. Girardi Surgical management of thoracic malignancies invading the heart or great vessels Ann. Thorac. Surg., September 1, 2004; 78(3): 1024 - 1030. [Abstract] [Full Text] [PDF]

				Y. Terada, N. Ono, T. Noguchi, K. Kamakari, and M. Kitano A case of thymoma protruding into the superior vena cava through the thymic vein Ann. Thorac. Surg., March 1, 2004; 77(3): 1088 - 1090. [Abstract] [Full Text] [PDF]

				J. T. Hartmann, L. Einhorn, C. R. Nichols, J.-P. Droz, A. Horwich, A. Gerl, S. D. Fossa, J. Beyer, J. Pont, H.-J. Schmoll, et al. Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis J. Clin. Oncol., March 15, 2001; 19(6): 1641 - 1648. [Abstract] [Full Text] [PDF]

				E. A. Rendina, F. Venuta, T. D. Giacomo, A. M. Ciccone, G. Ruvolo, G. F. Coloni, C. Ricci, and S. G. A. Patterson INDUCTION CHEMOTHERAPY FOR T4 CENTRALLY LOCATED NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 225 - 233. [Abstract] [Full Text] [PDF]

				N. Martini, A. Yellin, R. J. Ginsberg, M. S. Bains, M. E. Burt, P. M. McCormack, and V. W. Rusch Management of non-small cell lung cancer with direct mediastinal involvement Ann. Thorac. Surg., November 1, 1994; 58(5): 1447 - 1451. [Abstract] [PDF]

				J. A. Gonzalez-Fajardo, M. Garcia-Yuste, S. Florez, G. Ramos, T. Alvarez, and J. M. Coca Hemodynamic and cerebral repercussions arising from surgical interruption of the superior vena cavaExperimental model J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1044 - 1049. [Abstract] [Full Text]

				D. E. Van Raemdonck, A. Schneider, and R. J. Ginsberg Surgical treatment for higher stage non-small cell lung cancer Ann. Thorac. Surg., November 1, 1992; 54(5): 999 - 1013. [Abstract] [PDF]

				H. Inoue, A. Shohtsu, S. Koide, J. Ogawa, and H. Inoue Resection of the superior vena cava for primary lung cancer: 5 years' survival Ann. Thorac. Surg., October 1, 1990; 50(4): 661 - 662. [Abstract] [PDF]

				H. Masuda, T. Ogata, K. Kikuchi, and S. Tanaka Longevity of Expanded Polytetrafluoroethylene Grafts for Superior Vena Cava Ann. Thorac. Surg., September 1, 1989; 48(3): 376 - 380. [Abstract] [PDF]

				A. W. Lee, C. E. Reed, and J. M. Kratz Superior Vena Cava Bypass: Use of the Azygos Vein Ann. Thorac. Surg., December 1, 1988; 46(6): 686 - 687. [Abstract] [PDF]